Direct to consumer advertising
- PMID: 15626784
- PMCID: PMC539827
- DOI: 10.1136/bmj.330.7481.5
Direct to consumer advertising
Comment in
-
Direct to consumer marketing: advertising directly to consumers may affect patients' safety.BMJ. 2005 Apr 16;330(7496):906. doi: 10.1136/bmj.330.7496.906-b. BMJ. 2005. PMID: 15831888 Free PMC article. No abstract available.
-
Direct to consumer marketing: switch to over the counter can become indirect advertising directly to consumers.BMJ. 2005 Apr 16;330(7496):906. doi: 10.1136/bmj.330.7496.906-a. BMJ. 2005. PMID: 15831889 Free PMC article. No abstract available.
References
-
- Galbally R. Review of drugs, poisons and controlled substances legislation (the Galbally review): final report. Therapeutic Goods Administration (Australia), 16 October 2001. www.tga.health.gov.au/docs/html/rdpdfr.htm (accessed 11 Aug 2004).
-
- Brown B. Standing committee on health. Opening the medicine cabinet: first report on health aspects of prescription drugs. Ottawa, Ontario: House of Commons, 2004.
-
- United States General Accounting Office. FDA oversight of direct-to-consumer advertising has limitations. Report to congressional requesters GAO-03-177. October 2002. www.gao.gov/new.items/d03177.pdf (accessed 11 Aug 2004).
-
- National Institute for Health Care Management Research and Educational Foundation. Prescription drugs and mass media advertising, 2000. Washington, DC: NIHCM, 2001. www.nihcm.org/DTCbrief2001.pdf (accessed 14 Aug 2004).
-
- Woloshin S, Schwartz LM, Welch HG. The value of benefit data in direct-to-consumer drug ads. Health Affairs web exclusive 28 April 2004. http://content.healthaffairs.org/cgi/content/full/hlthaff.w4.234v1/DC1 (accessed 14 Aug 2004). - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources